Methods of localizing nucleic acids to arrays
Methods and compositions are disclosed relating to the localization of nucleic acids to arrays such as silane-free arrays, and of sequencing the nucleic acids localized thereby.
1. A method of localizing a target nucleic acid molecule to a solid support comprising:
providing a solid support comprising;
a surface;
a plurality of nucleic acids immobilized on the surface, wherein the nucleic acids in the plurality each comprise a primer sequence selected from SEQ ID NO:3 or SEQ ID NO:4;
providing the target nucleic acid molecule, wherein the target nucleic acid comprises a sequence that hybridizes to the primer sequence; and
hybridizing the target nucleic acid molecule to at least one of the plurality of nucleic acids immobilized on the surface, thereby localizing the target nucleic acid molecule to a solid support.
2. The method of claim 1 , further comprising:
contacting the target nucleic acid molecule hybridized to at least one of the plurality of nucleic acids immobilized on the surface with reagents necessary to synthesize a complement of at least part of the target nucleic acid molecule, wherein the complement to at least part of the target nucleic acid molecule is covalently bound to the 3′ end of at least one of the nucleic acids immobilized on the surface.
3. The method of claim 2 , further comprising separating the target nucleic acid molecule from said solid support.
4. The method of claim 3 , further comprising determining the sequence of the target nucleic acid molecule.
5. The method of claim 1 , wherein the surface comprises a hydrogel.
6. The method of claim 5 , wherein the thickness of the hydrogel is less than 100 nm.
7. The method of claim 5 , wherein the hydrogel is the product of polymerizing a first comonomer with a second comonomer, wherein the first comonomer is selected from the group consisting of acrylamide, methacrylamide, hydroxyethyl methacrylate and N-vinyl pyrrolidinone, and wherein the second comonomer is a functionalized comonomer selected from the group consisting of acrylamide, acrylate, methacrylate and methacrylamide.
8. The method of claim 1 , wherein the target nucleic acid molecule comprises a sequence that is reverse-complementary to the primer sequence.
9. The method of claim 1 , wherein the plurality of nucleic acids is immobilized on the surface via a linkage at their 5′ ends.
10. A composition comprising:
(a) a solid support comprising a surface; and
(b) a plurality of nucleic acids immobilized on the surface, wherein the nucleic acids in the plurality each comprise a primer sequence selected from SEQ ID NO:3 or SEQ ID NO:4.
11. The composition of claim 10 , wherein the nucleic acids are covalently attached to a hydrogel immobilized on the surface.
12. The composition of claim 11 , wherein of the hydrogel has a thickness less than 100 nm.
13. The composition of claim 11 , wherein the hydrogel is the product of polymerizing a first comonomer with a second comonomer, wherein the first comonomer is selected from the group consisting of acrylamide, methacrylamide, hydroxyethyl methacrylate and N-vinyl pyrrolidinone, and wherein the second comonomer is a functionalized comonomer selected from the group consisting of acrylamide, acrylate, methacrylate and methacrylamide.
14. The composition of claim 10 , wherein the nucleic acids in the plurality each comprise the primer sequence and a template, wherein the template comprises a nucleotide sequence that is longer than 300 nucleotides.
15. The composition of claim 10 , wherein the nucleic acids in the plurality each comprise a polyT spacer 5′ of the primer sequence 5′, wherein the polyT spacer comprises from 2 to 10 thymine nucleotides.
16. The composition of claim 10 , wherein the solid support comprises a silica-based substrate, plastic, gold, titanium dioxide or silicon.
17. The composition of claim 10 , wherein the nucleic acids in the plurality are hybridized to target nucleic acids comprising a sequence that is the reverse-complement of the primer sequence.
18. The composition of claim 10 , wherein the primer sequence is at the 3′ end of the nucleic acids in the plurality.
19. The composition of claim 10 , wherein the nucleic acids in the plurality further comprise a fluorescent label.
20. The composition of claim 19 , wherein the nucleic acids in the plurality further comprise a 3′ blocking group.